Panagora Asset Management Inc Ngm Biopharmaceuticals Inc Transaction History

Panagora Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$3.72 - $5.4 $469,635 - $681,728	-126,246 Reduced 80.97%	29,676 $121,000
Q4 2022 Feb 13, 2023	BUY	$3.41 - $12.93 $40,162 - $152,289	11,778 Added 8.17%	155,922 $782,000
Q3 2022 Nov 14, 2022	BUY	$12.59 - $17.67 $612,365 - $859,451	48,639 Added 50.93%	144,144 $1.89 Million
Q2 2022 Aug 15, 2022	BUY	$10.58 - $17.5 $240,049 - $397,057	22,689 Added 31.16%	95,505 $1.22 Million
Q1 2022 May 12, 2022	BUY	$13.81 - $18.6 $79,407 - $106,950	5,750 Added 8.57%	72,816 $1.11 Million
Q4 2021 Feb 10, 2022	BUY	$17.26 - $22.02 $1.16 Million - $1.48 Million	67,066 New	67,066 $1.19 Million

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.